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A B S T R A C T
Introduction: Abnormal MRI ﬁndings localizing to the mesial temporal lobe predict a favorable outcome
in temporal lobe epilepsy surgery. The purpose of this study is to summarize the surgical outcome of
patientswho underwent a tailored antero-temporal lobectomy (ATL)with normal 1.5 TMRI. Speciﬁcally,
factors that may be associated with favorable post-surgical seizure outcome are evaluated.
Methods: A retrospective analysis of the Rush University Medical Center surgical epilepsy database
between 1992 and 2003 was performed. Patients who underwent an ATL and had a normal MRI study
documented with normal volumetric measurements of hippocampal formations and the absence of any
other MRI abnormality were selected for this study. Demographic information was collected on all
patients. Seizure outcomes were evaluated using Engel’s classiﬁcation. A two-sided Fisher exact test
with Bonferroni correction was performed in statistical analyses.
Results: Twenty-one (21) patients met the inclusion criteria of normal 1.5 T MRI and underwent a
tailored temporal lobectomy. Mean age at time of surgery was 28 years (SD = 8.1, range 11–44) and
mean duration of the seizure disorder was 13.4 years (range 2–36). Risk factors for epilepsy included
head injury (n = 4), encephalitis (n = 3), febrile seizures (n = 2), and 12 patients had no risk factors.
Pathological evaluation of resected tissue revealed no abnormal pathology in 12/21 patients (57%). After
a mean 4.8 years follow-up post-surgical period, 15/21 (71%) patients were free of disabling seizures
(Engel I outcome). At 8.3 years follow-up, 13/21 (62%) patients had similar results. Absence of prior
epilepsy risk factors was the only statistically signiﬁcant predictor of an Engel class I outcome
(p < 0.0022).
Conclusion: Patientswithmedically intractable epilepsy and normalMRI appear to beneﬁt from epilepsy
surgery. Absence of prior epilepsy risk factors may be a positive prognostic factor.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.1. Introduction
The advent of magnetic resonance imaging (MRI) has signiﬁ-
cantly advanced the ﬁeld of epilepsy. In patients with medically
intractable temporal lobe epilepsy (TLE), visualization of a lesion or
evidence of mesial temporal sclerosis (MTS) has been reported to
be a prognostic indicator of good surgical outcome.1–6 When
paired with concordant data from electrophysiologic and func-
tional neuroimaging studies (PET, MRS), MRI ﬁndings that localize
to the mesial temporal lobe are associated with post-surgical§ Portions of this work were previously presenting in podium presentation form
at the 2008 AANS Annual Conference; Chicago, IL, April 28, 2008.
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doi:10.1016/j.seizure.2011.02.013seizure-freedom in 70–90% of patients.3,4,7–11 Conversely, locali-
zation is challenging when the MRI is normal, reﬂected in a
historically less favorable surgical outcome.12–22
Surgical planning of medically refractory epilepsy begins with a
thorough history and physical examination followed by video-
electroencephalographic (EEG) monitoring studies in order to
localize the epileptogenic zone, and high resolution MRI studies of
the brain. When the latter are normal, functional neuroimaging
studies can be used to conﬁrm a temporal epileptogenic focus.
Such is the case in 18–37% of all intractable epilepsy patients who
have no abnormalities on MRI despite an identiﬁable focus on EEG
studies.14,17,19–21
The purpose of this study is to investigate the post-surgical
seizure outcome of patients with pharmaco-resistant TLE who had
a normal 1.5 T brain MRI studies with documented normal
volumetric measurements of the hippocampal formation. In
addition, we attempted to identify variables associated withvier Ltd. All rights reserved.
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arily generalized tonic-clonic seizures).
2. Materials and methods
A retrospective analysis of the Rush University Medical Center
surgical epilepsy database between 1992 and 2003was performed.
The search identiﬁed 248 patients with TLE. The standard pre-
operative evaluation of surgical patients at our institution includes
an extensive history and physical examination and has been
reported in previous studies.23 In brief, patients undergo video-
EEG scalp electrodes and often sphenoidal electrodes placed under
ﬂuoroscopic guidance. High resolution MRI studies are carried out
in all patients. Imaging sequences consist of sagittal and axial pre-
and post contrast T1-weighted acquisitions, axial T2-weighted
acquisition, coronal FLAIR and Proton Density images, coronal
post-contrast T1 and T2-weighted images, and coronal spoiled
GRASS acquisition images targeted to the hippocampal formations
for volumetric analysis. The protocol used to measure the volume
of hippocampal formation has been described in a previous
publication.24 In eight patients, subdural electrodes were placed in
an initial procedure for more extensive monitoring particularly
when the focus was left sided, to aid in language mapping, and in
cases with non-corcordant data from other localized studies. In all
patients, the epileptogenic zone was conﬁrmed with intra-
operative electrocorticography using a 40 electrode grid posi-
tioned over the temporal lateral convexity and strips covering
basal temporal, orbito-frontal and basal-temporal occipital cortex.
The procedure performed was a tailored antero-temporal
lobectomy (ATL). Cortical resection was performed to remove
the epileptogenic zone with average extent of resection being
4.6 cm (range 1.5–7 cm) from the temporal tip. Care was taken to
remain conservative in language dominant temporal lobes versus
larger resections, if necessary, in non-dominant lobes and where
lateral seizure foci were identiﬁed. In each case the entire
amygdala was resected, although hippocampal resection varied
between partial (to the choroidal point) and complete (to the tectal
plate).
Inclusion criteria for the study were surgical cases demonstrat-
ing an epileptogenic zone in the temporal lobe in the absence of
any abnormalities on MRI, including normal volumetric analysis
and post-surgical seizure outcome data with a minimum of a two-
year post-surgical period. Of the 248 patients, 21 (8%) met these
criteria and were included in the series. Demographic informationTable 1
Patient demographics.
Demographics
Male 8
Female 13
Right lobectomy 11
Left lobectomy 10
Mean age at surgery (years) 28 (range 11–4)
Mean seizure duration (years) 19.1 (range 2–36)
Mean seizure freq/month 15 (range 6–20)
Head injury 4
Encephalitis 3
Febrile seizure 2
PET or SISCOM imaging 13
PET only 11 (8 localizing)
SISCOM only 2 (0 localizing)
Subdural electrodes 8
Normal pathology 12
Hippocampal sclerosis 6
Heterotopia 2
Dysembryoblastic neuroepithelial tumor 1
Extent of resection 4.6 cm (range 1.5–7 cm)
Mean follow-up 8.5 yrs (range 4–14yrs)collected on all patients is included in Table 1, in addition to
gender, side of operation, age at time of surgery, duration of seizure
disorder, risk factors for epilepsy, use of functional neuroimaging
(PET, SISCOM), use of video-EEG with intracranial recordings,
presence of abnormal pathology in resected tissue, extent of
resection, seizure focus location, and mean follow-up. Neuropsy-
chological results were uniformly obtained preoperatively in all
patients, but not uniformly postoperatively and therefore have
been excluded.
Functional neuroimaging studies were carried out in 13
patients; 11 had a positron emission tomography study (PET)
with 15 mCi of ﬂuorine-18 deoxyglucose (PET) and two had a
subtraction ictal SPECT co-registered to MRI (SISCOM) study using
25.1 mCi of technetium-99 m hexamehylpropylamine oxime
[Tc99m-HMPAO (Ceretec)].
Pathology specimens were obtained from all included patients
and evaluated for microscopic evidence of pathology by an
attending neuropathologist. Patients were followed for the
duration of the study for assessment of seizures outcome at the
Rush University Medical Center epilepsy clinic. Seizure outcomes
were classiﬁed according to Engel’s four categories; class I being no
seizures, class II being rare seizures, class III being limited
improvement, and class IV being no improvement or worsened
seizures.
Statistical analyses were carried out with a two-sided Fisher
exact test to evaluate the association between Engel class I seizure
outcome and each of the recorded variables. A Bonferroni
correction was performed given the high number of variables
included.
3. Results
Among the 21 patients, 11 (52%) underwent a right ATL and 10
(48%) a left-sided resection. Identiﬁed risk factors for epilepsy
included a prior history of head injury (n = 4), encephalitis (n = 3),
febrile seizures (n = 2), while no risk factor was identiﬁed in 12
patients. Among the 11 patients who underwent a PET study only,
8 were localizing to one temporal lobe, while none of the SISCOM
studies performed in 2 patients yielded localizing data. Two post-
operative patients who did not improve after resection underwent
post-operative PET/SISCOM studies and both patients localized to
the frontal lobe.
All patients underwent intraoperative electrocorticography.
Subdural electrodes were placed in 8/21 patients in a separate
procedure prior to resection. Three of these 8 patients had
localizing PET studies while the remaining 5 patients had
nonlocalizing or no metabolic imaging performed. Six of the 21
patients had a lateral seizure focus, while 15/21 had amesial focus.
Pathological evaluation of resected tissue revealed no abnormal
pathology in 12/21 (57%) patients. Six patients (28.5%) had
hippocampal sclerosis, 2 (9.5%) had heterotopia, and 1 (5%) had
evidence of dysembryoblastic neuroepithelial tumor that was
found anterior to the hippocampus and did not appear on any pre-
operative MRI sequence.Table 2
Engel class outcomes.
Engel class Number of patients at mean follow-up
(%)
4.8 years 8.3 years
I 15 (71%) 13 (62%)
IA 9 (43%) 9 (43%)
II 2 (10%) 4 (19%)
III 3 (14%) 4 (19%)
IV 1 (5%) 0 (0%)
Table 3
Variables predicting outcome.
Variable predicting Engel class I outcome p-Value
Absence of risk factor 0.0022
Side of surgery 0.02
Extent of resection 0.08
Mean follow-up 0.18
Metabolic imaging 0.39
Seizure frequency 0.39
Mesial versus lateral seizure focus 0.63
Hippocampal resection 0.67
Age at surgery 1.0
Abnormal pathology 1.0
Subdural electrodes 1.0
Duration of epilepsy 1.0
Sex 1.0
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mean 4.8 years follow-up, 15/21 (71%) of patients had excellent
seizure control (Engel class I), which was 13/21 (62%) at 8.3 years
follow-up.
There was no mortality in the studied patient population. Two
patients (9.5%) had transient post-operative anomia, which
resolved over time.
Statistical analysis of factors affecting Engel class I outcome are
shown in Table 3. Absence of prior epilepsy risk factors was the
only statistically signiﬁcant predictor of Engel class I outcome
(p < 0.0022). Due to the high number of variables present, a
Bonferroni correction was performed which lowered the alpha
level of each variable to 0.0045. Eleven out of 12 patients (92%)
without any identiﬁable risk factor had an Engel class I outcome,
whereas 2/9 patients (22%) of patients with a risk factor had Engel
class I outcomes. Table 4 describes localizing tools (imaging or
recordings) in relation to outcome.
4. Discussion
Surgery on temporal lobe epilepsy with imaging evidence of
pathology yields excellent results in carefully selected patients.
The problem arises when the MRI study fails to reveal an
anatomic lesion that corresponds to the electrophysiological
data. Early studies reported post-operative seizure-free rates in
patients with normal MRI studies as low as 29%.12–22 However,
with improvements in functional neuroimaging studies, seizureTable 4
Localizing studies and identiﬁed seizure focus location related to seizure outcome.
Patient PET SPECT Subdural electr
1 None None None
2 None None None
3 None None Yes
4 None None None
5 None None None
6 None Non localizing None
7 Localizing None None
8 Localizing None None
9 Localizing None None
10 Non localizing None None
11 Non localizing None Yes
12 Localizing None Yes
13 None None None
14 Localizing None None
15 Localizing None Yes
16 Localizing None Yes
17 Localizing None None
18 None None Yes
19 Non localizing None Yes
20 None Non localizing None
21 None None Yeslocalization has improved with a resultant more favorable
outcome in surgery. Siegel et al.19 reported on 24 patients with
focal epilepsy and normal MRI studies. Ictal as well as interictal
SPECT studies were utilized in addition to the traditional scalp
and/or invasive EEG monitoring. Eighty-three percent of
patients had satisfactory outcome with 15 (62%) of them being
seizure-free at two years or greater follow-up (Engel class I). In
similar fashion, Bell et al.13 analyzed their forty-four patients
with normal 1.5 or 3 T MRI’s undergoing anterior temporal
lobectomy. Of note, eleven of these patients were found on re-
review of the MRI’s to have subtle hippocampal or amygdaloid
abnormalities, and this cohort trended towards improved
outcomes. Overall, sixty percent had Engel class I outcome at
greater than 1 year, with 47.5% achieving class Ia status. No
preoperative risk factors predicted statistically signiﬁcant
improved outcome in their series, although negative scalp
EEG and localizing SISCOM both exhibited improved trends.
In the presented series of 21 patients, 15 (71%) were seizure-
free at average 4.8 years follow-up. This number decreased to 13
(62%) patients by 8.3 years of follow-up.
According to our analysis, two of the patients with an Engel
class I at 4.8 yearsworsened to a class II at 8.3 years (in reference to
Table 4, patient #2 worsened at the 99th postoperative month and
patient #6 at the 100th postoperative month), while the one Engel
class IV patient at 4.8 years improved to Engel class III at 8.3 years
(in reference to Table 4, patient #17 improved at the 100th
postoperative month).
Absence of prior seizure risk factors appears to predict a
favorable outcome based on the statistical analysis (p < 0.0022).
The results are very plausible, as some of the risk factors identiﬁed
(head injury and encephalitis) tend to injure the brain diffusely.
Therefore, a unilateral resectionmay not improve seizure outcome
in this patient population. This is an important ﬁnding and addition
to the literature as it helps with the decision to consider surgery or
intracranial monitoring.
We initially thought that age at the time of surgery would be a
predictor of good seizure outcome, but this did not reach clinical
signiﬁcance in our cohort (p = 1). Younger age has been associated
with improved seizure control in prior literature, hypothetically
resulting from the younger neural tissue, per se, and not the
duration of chronic seizure activity.6,16,22
Of interest, complete hippocampal resection to the tectal plate
as compared to only partial resection (resection to the choroidalode Mesial versus lateral focus Engel outcome at 8.3 years
Mesial I
Mesial II
Lateral I
Mesial I
Mesial I
Mesial II
Mesial I
Lateral I
Mesial I
Mesial I
Mesial III
Mesial I
Mesial I
Lateral I
Mesial I
Lateral II
Mesial III
Mesial I
Lateral III
Lateral III
Mesial I
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partial resections tended to be performed early in the study while
complete resections tended to be performed later.
It would be interesting to correlate extent and side of
resection to neuropsychological outcomes, as this was not
evaluated and is a limitation in our series. We are aware of
previous reports suggesting neuropsychological changes follow-
ing similar procedures. This is an area we are currently
exploring.
We attribute our favorable seizure outcomes to several factors.
Careful selection of patients with convergent conﬁrmatory data,
however, is most critical. A thorough clinical history evaluating for
the presence of symptoms attributable to a temporal lobe focus is
paramount to localizing seizures. In fact, speciﬁc distinctions
betweenmesial versus lateral temporal lobe source of seizures can
sometimes be predicted based on a detailed seizure history.2,25,26
Furthermore, the presence of a discreet zone of low voltage fast
activity and a prolonged conduction time has independently
shown to be associated with an improved surgical out-
come.7,11,12,20,26
Ictal SPECT and 18-ﬂuordesoxyglucose (18FDG) PET studies
have been shown to accurately localize temporal lobe foci in 73% of
cases.10,27–30 This number is comparable to the predictive accuracy
of subdural electrodes. The use of SISCOM is also routinely used at
our institution. O’Brien et al.31 demonstrated that SISCOM images
were localizing in 45/51 (88.2%) of temporal lobe patients
compared to 20/51 (39.2%) of patients whose ictal and interictal
SPECT images were inspected by the traditional side-by-side
method (p < 0.001). Bell et al.13 demonstrated an improved trend
in outcome when SISCOM was localizing in their series. Proton
magnetic resonance spectroscopy (1H-MRS) has also been used in
normal temporal lobe epilepsy. Decreased ratios of ictal focus N-
acetyl aspartate to choline have been shown in the majority of
these patients.32,33
Invasive monitoring by placement of subdural or epidural
electrodes is employed in many of our more recent normal MRI
temporal lobe operations. Data from these recordings provide
information to further elucidate a mesial versus lateral source of
seizures. In addition, mapping of the lateral cortical areas allows
for a ‘‘tailored’’ temporal neocorticectomy in addition to resection
of the mesial structures.
Finally, it is important to note that normal 1.5 T MRI with thin
cut protocol does not necessarily predict normal pathology. Nine of
21 of our patients (43%) had abnormal pathology, including
hippocampal sclerosis, heterotopia, and even dysembryoblastic
neuroepithelial tumors. This can directly be attributable to the
1.5 T power of the MRI. Numerous reports exist showing improved
lesion recognition through the use of 3 T MRI.34–37 The higher
signal-to-noise ratio of high-ﬁeld MR systems provides this
increased anatomic resolution. Although it is unclear if re-review
showing subtle abnormalities in eleven of their 44 patients could
be attributable to 1.5 T versus 3 TMRI in the Bell et al.13 series, they
insightfully acknowledge that subtle ﬁndings may in fact be
present but missed. On re-review of the MRI’s in our series, subtle
ﬁndings continue to be absent. However, 3 T MRI was not been
applied to this cohort. Knake et al.35 used 3 T MRI to identify focal
lesion in 15 of 23 patients (65%) whose 1.5 T MRI were normal.
Because of this, we now commonly use 3 T MRI in cases of normal
1.5 T MRI.
While we believe our results illustrate important ﬁndings
regarding surgery in patients with normal 1.5 T MRI, a few
limitations should be highlighted. This was a retrospective study
describing seizure outcomes in a small cohort, primarily due to the
limited number of patients ﬁtting our criteria. Additionally,
correlative neuropsychological data is not included due to our
continued investigation using this outcome measure.5. Conclusion
Patients with medically intractable epilepsy and normal 1.5 T
MRI who have good ictal and interictal localization to a single
temporal lobe and convergent conﬁrmatory testing are likely to
beneﬁt from temporal lobe epilepsy surgery. Absence of epilepsy
risk factors, such as head trauma, encephalitis, or febrile seizures
was a statistically signiﬁcant predictor of good outcome in our
series.
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